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Abstract: Background: the main objective of this study was to analyze the potential short-, medium-
and long-term effects of a therapeutic physical exercise (TFE) programme on the functionality of amy-
otrophic lateral sclerosis (ALS) patients, measured with the Revised Amyotrophic Lateral Sclerosis
Functional Scale (ALSFRS-R) scale. Methods: a systematic review of the PubMed, SCOPUS, Cochrane,
Scientific Electronic Library Online (Scielo), Physiotherapy Evidence Database (PEDro), Cumulative
Index of Nursing and Allied Health Literature (CINAHL) and Medical Literature Analysis and
Retrieval System Online (MEDline) databases was carried out. The information was filtered using the
following Medical Subjects Heading (MeSH) terms: “Amyotrophic lateral sclerosis”, “Physical Ther-
apy”, and “Physical and Rehabilitation Medicine”. The internal validity of the selected documents
was evaluated using the PEDro scale. The study included clinical trials published in the last 5 years
in which one of the interventions was therapeutic physical exercise in patients with ALS, using the
ALSFRS-R as the main outcome variable and functional variables as secondary variables. Results:
10 clinical trials were analyzed, with an internal validity of 5–7 points. The TFE groups showed
significant short-, medium- and long-term differences, obtaining a mean difference of 5.8 points
compared to the 7.6 points obtained by the control groups, at six months, measured with ALSFRS-R.
In addition, the participants showed significant improvements in functional abilities in the short,
medium and long terms. Conclusions: Therapeutic physical exercise could contribute to slowing
down the deterioration of the musculature of patients with ALS, thus facilitating their performance in
activities of daily living, based on the significant differences shown by these individuals in the short,
medium and long term both in subjective perception, measured with ALSFRS-R, and functional
capacities.
Keywords: amyotrophic lateral sclerosis; physical therapy; rehabilitation; exercise
1. Introduction
Amyotrophic lateral sclerosis (ALS) is a disease of the central nervous system (CNS)
and is characterized by a progressive involution of motor neurons in the cortex of the
brain (upper motor neurons) [1]. As a consequence, muscle weakness occurs, which
causes paralysis, spreading from different body regions. It compromises motor autonomy,
written and oral communication, swallowing and breathing; however, the ocular muscles,
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sensitivity and intellect are not altered [2]. The clinical manifestations of ALS are due to
the abnormal behavior of the nervous system [3].
The treatment of this disease must be comprehensive and must be approached from a
multidisciplinary point of view, from the moment it is diagnosed until its terminal phase.
It includes pharmacological, neurorehabilitation and symptomatic treatments [4]. Physical
therapy consists in planned therapeutic physical exercise to correct postural abnormalities,
combat pain and reduce muscle stiffness. In addition, it promotes functional independence,
trains the patient to prevent falls, and re-educates walking, with certain technical aids if
necessary [5]. The role of physical exercise begins prior to significant loss of strength and
continues throughout the course of the disease, up to the last days of the person’s life.
Everything indicates that exercise can be physically and psychologically important
for people with ALS; however, although recent studies focus on what type of exercise is
most indicated for these patients, there is still no evidence of this or at what frequency
or intensity should exercise be performed in training sessions or to what extent it helps
patients maintain functionality.
On the other hand, the process of evaluating the patient is very important in order to
analyze the effects of the intervention that is being used. In this sense, having a tool that
allows studying the status and evolution of the patient with ALS is very important [6,7]:
The Revised Amyotrophic Lateral Sclerosis Functional Scale (ALSFRS-R) is a measure used
to assess the status and progression of patients with ALS. It is one of the most widely used
scales to assess the functionality of these patients. The main components of this scale are [4]:
bulbar function: language, salivation and swallowing; fine motor: writing, use of cutlery,
dressing and personal hygiene; gross motricity: rolling over in bed, walking and climbing
stairs; and respiratory function: dyspnoea, orthopnoea and respiratory insufficiency. It
is common for people with ALS to obtain their diagnosis 1 year after the onset of the
disease and with a score greater than 39 on the ALSFRS-R scale [7]. Using a common
assessment tool in patients with ALS allows comparing the effects of the different proposed
interventions. Furthermore, due to the functional impairment suffered by this type of
patient, specifically analyzing their functional capacities is also relevant.
No systematic review has been found to analyze the effect of therapeutic physical exer-
cise in patients with ALS in the short, medium and long term. Therefore, the main objective
of this study was to analyze the potential short-, medium- and long-term effectiveness of a
therapeutic physical exercise programme on the functionality of patients suffering from
ALS, measured with the ALSFRS-R scale. The secondary objective of this systematic review
was to analyze the effect of therapeutic physical exercise on functional variables in patients
with ALS in the short, medium and long term.
2. Materials and Methods
2.1. Search Strategy
To carry out this systematic review, information collected from the PubMed, SCOPUS,
Cochrane, Scientific Electronic Library Online (Scielo), Physiotherapy Evidence Database
(PEDro), Cumulative Index of Nursing and Allied Health Literature (CINAHL) and Medical
Literature Analysis and Retrieval System Online (MEDline) databases was used. For the
selection of the information, descriptors obtained from Medical Subjects Heading (MeSH)
were used. The information was filtered using the following keywords: “Amyotrophic
lateral sclerosis”, “ALS”, “Motor Neuron Disease”, “Physical Therapy”, “Exercise Therapy”,
“Physical and Rehabilitation Medicine”, and “Exercise Training”. A systematic review
of the scientific literature was carried out following the Preferred Reporting Items for
Systematic Reviews and Meta-Analyses (PRISMA) model (Figure 1). The search was
carried out between 15 and 30 June 2020. The PICOT (Patient; Intervention; Comparison;
Outcome; Time) methodology was followed to evaluate the effect of therapeutic physical
exercise, in the short, medium and long term, in patients with ALS, compared with control
groups and evaluated with the ALSFRS tool-R, as the main outcome variable, and with
functional tests, as secondary variables.
Int. J. Environ. Res. Public Health 2021, 18, 1074 3 of 15
Figure 1. Search flow chart according to PRISMA model.
2.2. Selection Method
Two researchers with more than 10 years of experience in the selection of documents
performed the blind selection of the different documents. After applying all the previously
described criteria, those that were duplicated were discarded and the selected articles were
read in full by the authors. In the event of a discrepancy in any criteria, a third researcher
(blinded) with more than 15 years of experience in document selection, decided if the paper
should be included.
2.3. Selection of Documents
The following inclusion criteria were established: clinical trials published in the last
5 years, with at least one of the interventions being therapeutic physical exercise in patients
with ALS, which included the values of the ALSFRS-R as an outcome variable of patients
who underwent study, in addition to obtaining a score ≥5 on the PEDro methodological
quality scale.
The following exclusion criteria were assigned: score <5 on the PEDro methodological
quality scale; the absence of the outcome variable ALSFRS-R among the measurement
values; trials with exclusively respiratory/bulbar rehabilitation programmes; or trials
involving animals. Furthermore, studies that were not published in English, Spanish,
French, Portuguese or Italian were excluded.
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2.4. Evaluation of the Internal Validity of the Selected Documents
The PEDro methodological assessment scale was applied to estimate the quality of the
analyzed studies [8]. This scale consists of 10 items plus selection criteria: (1) randomization
of the sample; (2) concealed allocation; (3) initial comparability between groups; (4) all sub-
jects blinded; (5) all therapists who administer therapy blinded; (6) all evaluators measuring
key outcomes blinded; (7) adequacy of follow-up; (8) analysis with intention to treat; (9) sta-
tistical comparison of results between groups; and (10) existence of specific measures and
variability for at least one key result. These items are dichotomous (i.e., 1 point per item),
thus points were obtained based on compliance with the requirements of each particular
item [8].
Studies with a score ≥6 were considered high-quality studies.
3. Results
Initially, 753 documents were found in the PubMed, SCOPUS, Cochrane, SciELO,
PEDro, CINAHL and MEDLINE databases. The following were excluded: 467 duplicates,
155 older than 5 years, 84 non-clinical trials, 11 animal studies, 9 that only contained bulbar
rehabilitation and 17 that did not include the main outcome variable of the ALSFRS-R.
After this, 10 clinical trials were analyzed in full-text and included (Figure 1).
The 10 selected clinical trials were evaluated with the PEDro scale. The score ranged
from 5 to 7 points. Four of the studies obtained 5 points, three of them obtained 6 points
and the rest obtained 7 points. Furthermore, none of them were masked, and they all
included the results of the primary variable (Table 1).
The characteristics of all the documents were analyzed (Table 2). As can be seen, a
total of 421 patients were test subjects, of which 183 underwent rehabilitation with physical
exercise and were part of the group of cases; the rest of the participants belonged to the
control group and their treatment was mostly passive. The mean age of the patients was
60 years, and the mean time they suffered from the disease was 15 months.
Some of the therapeutic physical exercise interventions consisted of aerobic exercise [9,10],
moderate-high-intensity strength and endurance exercises [5,11–13], functional training or
stretching [14,15]. Frequencies ranged from highest to lowest [10] according to the study,
and the intervention time was a minimum of 2 weeks and a maximum of 6 months. The
exercises were performed at around 70% heart rate (HR), and the strength of each patient
was measured in order for them to avoid exceeding 80% of their MR.
The outcome variables of each article were analyzed. The main one was the ALSFRS-R
functionality scale (Table 3), in which the score ranged between 32 and 43 points for the
initial minimum and maximum score, respectively. In addition, these documents included
secondary variables, such as forced vital capacity (FVC), fatigue severity scale (FSS) and
6 min walking test (6MWT). The scores were collected at the start of the treatment and in the
short, medium and long term. They were divided into two tables: ALSFRS-R (all studies)
(Table 3) and FVC, FSS, and 6MWT (7/10 studies were included) (Table 4). We chose these
variables according to their relevance and the frequency with which they occurred in the
analyzed studies. Both tables show the evolutionary comparison of cases and controls, in
addition to the standard deviation of each data unit.
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Table 1. Physiotherapy Evidence Database (PEDro) scale total score of the different studies included.























Marques Braga et al.,
(2018) [9] ECA • - • - - - - • • • 5
Kitano et al., (2018)
[14] EC - - • - - - • • • • 5
Sivaramakrishnan
et al., (2019) [16] EC - - • - - - • • • • 5
Clawson et al., (2017)
[13] ECA • - - - - • • • • • 6
Kato et al., (2018) [5] EC - - • - - - • • • • 5
Van Groenestijn et al.,
(2019) [17] ECA • - • - - • • • • • 7
Ferri et al., (2019) [12] ECA • - • - - - • • • • 6
Merico et al., (2018)
[11] ECA • - • - - • - • • • 6
Zucchi et al., (2019)
[10] ECA • - • - - • • • • • 7
Lunetta et al., (2015)
[15] ECA • - • - - • - • • • 6
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Table 2. Characteristics of the included studies.
Author Sample Size Age (Years) ALS Time Intervention Session Frequency Outcome Variables
Marques Braga et al.,
(2018) [9]
50 (48)
G1 = SC: 25 (24)
G2 = AECI: 25 (24)
G1: 63 (±13.0)
G2: 62 (±12.0)
G1 = SC: 9.5 months
G2 = AECI: 9 months
G1 AECI: Aerobic exercise of
controlled and moderate
intensity + SC









Kitano et al., (2018) [14]
105 G1 = Home-ex: 21
(15)
G2 = Control: 84
G1: 62.8 (±10.2)
G2: 62.7 (±12.1)
G1: 2.2 (±2.4) years
G2: 1.5 (±1.7) years
Strength, functional and
stretching exercises for upper
limbs and trunk muscles
Daily/individualized









G1: 59.22 (±12.3) G1: 2.37 (±1.9) years
Reclining stepped aerobic
exercise of moderate intensity.
70 steps/minute.
40 min.





Clawson et al., (2017)
[13]
59
G1 = ROM: 21
G2 = RESISTANCE: 18








G1: Held stretches (30 s)
G2: strength exercises (70% RM)
G3: moderate/high intensity
resistance exercises.
















Van Groenestijn et al.,
(2019) [17]
57 (32)
G1 = AET: 27 (10)






G1 AET: Aerobic exercise
therapy in cycle ergometer + UC
G2 UC: usual care
50 min.















intensity aerobic and strength
exercise.
G2 UC: usual care
50 min.




VO2 MAX, Mc GILL
Merico et al., (2018) [11]
38
G1 = EP: 23






G1 EP: Submaximal aerobic
exercise 65% HR and 80%
strength RM
G2 SNT: neuromotor standard
exercise
50 min.





Int. J. Environ. Res. Public Health 2021, 18, 1074 7 of 15
Table 2. Cont.
Author Sample Size Age (Years) ALS Time Intervention Session Frequency Outcome Variables
Zucchi et al., (2019) [10]
65
G1 = IER: 32






G1: High frequency aerobic and
resistance training.
G2: Aerobic exercise, low
frequency.
45 min.








Lunetta et al., (2015) [15]
60 (47)
G1 = SMEP: 30 (22)






G1 SMEP: passive, active and
cycle ergometer exercises,
strictly supervised.
G2 UCP: passive habitual care.




ALSFRS-R: revised functional scale for amyotrophic lateral sclerosis, ALSAQ-40: Assessment of subjective health status in amyotrophic lateral sclerosis, ASS: Ashworth Spasticity Scale, BDI: Beck’s depression
inventory, CPET: cardiopulmonary exercise test, FAC: functional walking test, FIM: functional measure of independence, FSS: fatigue severity scale, FVC: forced vital capacity, KC: creatine kinase, KEMS: strength
knee extensor muscles, MCS: mental component summary, MMT: manual muscle test, PCS: physical component summary, ROM: Range of Motion; TUG: get up and walk test, VAS: visual analog scale, VO2Máx:
maximum oxygen consumption, 6MWD: 6 min walk test.
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Table 3. Summary of the ALSFRS-R outcome variable.








et al. (2018) [9]
Cases 40.25 (±5.00) - - 34.1 (±7.1)
Control 37.25 (±4.9) - - 29.5 (±7.7)
Kitano et al.
(2018) [14]
Cases 41.1 (±4.5) - - 38.1 (±5.9)
Control 40.3 (±4.4) - - 33.1 (±9.2)
Sivaramakrishnan
et al. (2019) [16]
Cases 32.75 (±7) 33.25 (±7.55) 32.62 (±7.4) -
Control 32.75 (±7) - - -
Clawson et al.
(2017) [13]
Cases 39.36 (±4.92) - - 35.41 (±1.26)
Control 39.67 (±3.71) - - 33.54 (±1.38)
Kato et al.
(2018) [5]
Cases 43 (±2) - - 37.5 (±1)
Control 43 (±2) - - -
Van Groenestijn
et al. (2019) [17]
Cases 42.4 (±4.3) - 40.52 (±3.48) -
Control 42.2 (±3) - 38.28 (±5.52) -
Ferri et al.
(2019) [12]
Cases 40.4 (±1.5) - 35.7 (±2.6) -
Control 35 (±3.4) - 23 (±5.6) -
Merico et al.
(2018) [11]
Cases 36.1 (±4.71) 36.1 (±4.71) - -
Control 34.5 (±3.6) 34.5 (±3.6) - -
Zucchi et al.
(2019) [10]
Cases 39.84 (±5.7) - 34.87 (±8.49) 33.08 (±9.76)
Control 40.15 (±5.17) - 36.39 (±8.01) 33.0 (±9.42)
Lunetta et al.
(2015) [15]
Cases 39.1 (±4.7) 37.0 (±5.1) 35.1 (±6.2) 32.8 (±6.5)
Control 38.3 (±5.1) 38.1 (±4.3) 34.3 (±6.4) 28.7 (±7.5)
Table 4. Summary of secondary outcome variables FVC, FSS, 6MWD.
Variable Study Baseline
End of Study
1 Month 3 Months 6 Months
FVC (%)
Clawson LL
et al. (2017) [13]
Cases 88.14 (±11.03) - - 74.34
Control 91.19 (±77.9) - - 88.59
Lunetta et al.
(2015) [15]
Cases 92.5 (±23.3) - - 75.8 (±23.6)
Control 93.9 (±14.7) - - 66.5 (±26.9)
Kato et al.
(2018) [5] Cases 69.05 - - 72.2
Van Groenestijn
et al. (2019) [17]
Cases 86.9 (±20.2) - 79.22 -
Control 95.4 (±15.4) - 81.88 -
Zucchi et al.
(2019) [10]
Cases 91.88 (±18.98) - - 66.24 (±44.96)











Cases 5.4 (±0.27) 6.69 (±0.21) -
Control 5.4 (±0.2) 5.19 (±0.16) - -
Zucchi et al.
(2019) [10]
Cases 35.63 (±15.31)÷ 9 - -
41.42 (±18.49)
÷ 9











Cases 265.17 (±81.37) 336.73 (±50.72) - -
Control 236.26 (±76.26) 239.16 (±5.48) - -
%FVC: percentage of forced vital capacity, FSS: fatigue severity scale, 6MWD: 6 min walk test.
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4. Discussion
This study was focused on analysing the functional changes that a therapeutic physical
exercise programme can cause in patients suffering from ALS as measured by the ALSFRS-
R scale. After a search and exclusion of clinical trials in different databases (Figure 1),
10 of these studies were analyzed in full-text, which were evaluated using the PEDro
scale (Table 1). In them, 421 patients were analyzed between groups of cases (treated
with therapeutic exercise) and control groups (with habitual passive treatments), whose
results were obtained with different scales, mainly the ALSFRS-R (a scale of functionality
that is currently accepted to quantify the capacity of these patients to carry out their
routine activities [4]), and FSS, FVC and 6MWT were established as secondary measures,
based on their frequency of appearance and correlation with the study. Furthermore, due
to the different duration of each clinical trial, it was possible to determine the effect of
neurorehabilitation at different stages of the disease. Thus, the effect of the intervention can
be compared in the short, medium and long term and behavioral trends can be observed
between the scores of the different patients treated. Likewise, the following results were
obtained from them (Table 3).
In most of the clinical trials in which the effect of a treatment based on physical exercise
is studied in the progression of ALS, the strength of the patients is usually improved in
the trained muscles. However, there is still discrepancy regarding functionality. In fact,
there are claims about possible ineffectiveness in improving function in patients with
ALS through moderate- to high-intensity strength exercise therapy according to the Borg
Scale [18]. In this sense, it was found that, by training the lower limbs of the patients who
participated, they managed to increase strength in actions such as knee extension, although
with no progress in activities such as climbing stairs or walking. Faced with this question,
the results of the analyzed studies are broken down according to the moment.
4.1. Short-Term Effects
In the first month of rehabilitation, even improvements in the ALSFRS-R score can
be found [16]. This is a relevant fact, since, when dealing with the rehabilitation of a
degenerative disease, function is expected to be lost with the passage of time [3]. In fact, in
the rest of the trials in which measurements were taken after 1 month, it was found that the
scores of cases and controls decreased around 2 points [15] or remained the same [11]. This
is considered a positive aspect of progress and, in view of these qualifications, it seems that
therapeutic physical exercise manages to slightly improve (+0.5 points [16]), maintain [11]
or slow down the natural degenerative progress of the patients (−1.8 points [15]), as
observed when comparing the control groups of the respective selected trials.
Comparing the results of one of the groups with a study that carried out a follow-up
at 1 month, a significantly greater reduction in the score can be observed [15]. This could
be due to the frequency of intervention, since their groups performed physical exercise
only twice per week, which is a more reduced continuity than in the rest of the studies. In
addition, this trial included patients with a disease duration of <2 years and a very high
ALSFRS-R score (39.1 points). This fact did not occur in the rest of the patients and it may
indicate that the behavior of the pathology, which decreased at 1 month, could return to
the normal level of affectation in the medium term, since it is difficult to maintain such
high score levels in a disease that is characterized by the early degeneration of nervous
tissue [19].
It seems that, after a month of rehabilitation, the effects of physical exercise are still
not clear and that the hypertrophy caused by physical rehabilitation appears after one
month [18]. Prior to this, the so-called recruitment by collateral outbreak takes place, which
is caused by muscle cells without neurological damage [20]. This could explain why there
are some cases in which function is improved early in this type of rehabilitation. However,
in other pathologies, such as multiple sclerosis, there are studies in which improvements
in physical condition linked to quality of life have been observed in only 3 weeks of
rehabilitation training, with characteristics similar to the exercise plans proposed in the
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studied patients with ALS—moderate intensity, twice per week and aerobic skills combined
with strength exercise [21].
4.2. Medium-Term Effects
It seems that, within 3 months, significant differences begin to appear between the
groups treated with therapeutic exercise and those treated with passive conventional
treatment [12,15,17] (Tables 3 and 4). In all of them, the ALSFRS-R scores decreased
between 0.13 [16] and quasi 5 points [10,12] in the training group compared to those in
the control and passive therapy groups, which had a decrease in the greater functionality
score. However, a different outcome was also reported, in which a group of participants
who trained less frequently (two sessions/week) obtained better results than a group that
performed the exercises five times/week [10]. This fact supports the theory that training
must be balanced between muscle overwork and underwork [22]. This is also correlated
with the involutional factor of ALS, in which valid neurons decrease as time passes, and it
is recommended not to tire the patient [18], thus recommending a treatment with moderate
rather than intense tendency. In addition, a study states that mild and moderate exercises
(such as a swimming regimen) help to preserve motor neurons, and that more intense
levels obtain the opposite effect, even decreasing survival [23].
Furthermore, other studies have shown that there may not be significant differences
in physical health status in people with chronic musculoskeletal disorders who work out
twice per week compared to three times per week. This is to be expected, since, once a
point of maximum tolerated load has been reached, the benefits of training no longer show
significant improvements. Therefore, the costs of resources and treatments could be saved
without apparently affecting these results [24].
Regardless of the intensity and frequency of the sessions throughout the week, it
can be seen that the duration of therapy did not exceed 60 min per session in any of the
analyzed trials. Although the effort tolerance of a patient with ALS could be lower than
that of a healthy subject, this could lead to a regression in therapy and in their own disease.
Therefore, this must be explored, focusing on finding a balance between the accumulated
load and the frequency of sessions and their duration.
It was also observed that there were scores on the functionality scale that decreased
more than in the rest of the studies that carried out the measurement at 3 months and
whose cases and controls obtained very different results, since the points in the usual
care control patients dropped from 35 to 23 and from 40 to 35 in the motor rehabilitation
patients. However, this could be due to the fact that they started with 40 points, which is
significantly higher compared to the controls [12]. Regarding the sharp decrease in this
study in only 3 months in the score on the ALSFRS-R scale, the age of the patients in this
trial may have had an influence compared to the rest of the analyzed studies, since the
mean age in this study was 53, whereas in the other studies the mean age was 61 (Table 2).
This finding is related to the fact that, as a general rule, the musculoskeletal system of a
10-year-older adult will be more impaired or have more signs of muscle immobilization
than a 10-year-younger adult [25]. Therefore, in turn, this condition of weakness will show
more noticeable changes and advances in patients who entered the studies with worse
physical condition or, in this case, at an older age. In fact, elderly people with Parkinson’s
disease underwent strength training for 4 months and were compared with a control group
(passive) in terms of respiratory muscle strength and quality of life. The result was that
the older people who underwent active neurorehabilitation looked significantly better [26].
For this reason, the development of this type of protocol could be of interest, since previous
studies with different degenerative pathologies have shown effective results.
4.3. Long-Term Effects
A significant difference can be observed in most of the analyzed studies [9,14,15], with
differences ranging between 3 [14] and 6.76 [10] points, with respect to the record in the
baseline analysis. These values represent an involution of 6.25% and 14.1%, respectively, as
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patients treated with therapeutic exercise benefited most at a functional level compared
to those who continued with a more sedentary lifestyle, who experienced an involution
(measured with ALSFRS-R) of between 6.13 [13] and 9.6 [15], which implies an involution
(measured with ALSFRS-R, 0–48 points) of 12.77% and 20%, respectively. Some functional
results of groups (physical exercise or stretching) were similar; however, an analysis of the
falls of patients was subsequently carried out, showing that the group that worked with
strength and resistance had fewer falls compared to the group that worked with joint range
of motion and stretching [13]. Both the number and frequency of falls decreased in other
neurodegenerative pathologies (such as Parkinson’s disease) thanks to a programme of
therapeutic physical exercise [27].
However, functional improvements were seen in some patients only at the begin-
ning of treatment when their score was higher than 40 points. Then, they underwent
rehospitalization and physical exercise after those months proved to be of little efficacy in
more advanced stages, thus suggesting that some patients may not respond to this type
of therapy when their scores on the ALSFRS-R scale drop below 40 points and distance
themselves from the initial stages of the disease [5].
Analyzing and comparing the scores obtained in the studies that measured the
ALSFRS-R scale at 6 months, the behavior between the different groups of cases, but not of
controls, was similar. That is, the observed trend is for a drop of approximately 6 points on
the functionality scale in this period of time, having performed moderate-intensity physical
exercise regardless of whether it was focused on aerobic or strength exercise. However,
in the case of controls, there were groups that, with the usual therapy, dropped to 10
points from the start [9,15] or only between 4 and 7 points [10,13,14]. Therefore, it could
be inferred that, in a rehabilitation that did not include therapeutic physical exercise, the
possibilities of slowing down the disease would be exposed to heterogeneous conditions
and the patient’s own circumstances; however, with extra physiotherapy rehabilitation,
a non-evolutionary development could be expected. This is completely unfavourable for
the patient, and a controlled decrease in the ALSFRS-R score is usually associated with
managing activities of daily living, probably for a longer period of time than other patients
whose therapy is mostly passive.
Although most of the studies cited above and analyzed in this review obtained
satisfactory results with therapies based on therapeutic physical exercise, there remain
divergences in some other trials in which the progression of the disease was not stopped as
much as expected. This could be due to the possibility that some of these treated patients
may have exceeded the intensity of the exercise, since there seems to be a correlation
between patients who performed moderate exercise and a higher density of motor neurons
in the ventral horn of the spinal cord, which leads to initially slower muscle deterioration,
whereas the opposite occurs if the musculature is overloaded. Even sedentary patients can
show better progress than those who excessively reach fatigue [28].
In the longer term, if the training therapy exceeds 10 months, it seems that only a
partial improvement is observed [5], and routine activities become more difficult, thus the
ALSFRS-R score in the follow-up could plummet, as in the case of [10], where it was below
30 points. When this happens, most cells are usually poorly innervated, and it is up to the
“healthy” cells to counteract this weakness. For this reason, it is important to boost healthy
muscle cells in time, and physical therapy in ALS could be used preventively before the
onset of weakness in gait [18]. In this way, therapeutic exercise would be recommended to
be implemented before and during the onset of the disease [5].
Neurorehabilitation with physical exercise seems to help strengthen the musculature
in its “disuse factor”; therefore, patients with ALS who started with physical exercise
and who were previously sedentary or were hospitalized would have greater results than
patients who started rehabilitation in good shape [10]. This could be one of the reasons
why the analyzed studies varied in terms of results and a common improvement trend was
not obtained in all the exercised groups.
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Although some groups of cases achieved greater progress than their control groups in
terms of functionality, the same was observed regarding survival, which was not related
to the ALSFRS-R score [9]. It seems that the measures of this scale are not linked to the
probability of surviving a longer time [10].
However, some aspects were correlated with this scale, such as a deceleration of
muscular atrophy that is normally caused by progressive inactivity, which is responsible
for the involutional character of this disease [11]. In addition, aerobic fitness and respiratory
function are benefited [12,14]. It is even inferred that these two aspects could influence
factors such as appetite, sleep or mood [29]. For this reason, other secondary outcome
variables that appeared in the reviewed studies were analyzed, which will allow relating
the functionality of the ALSFRS-R scale with other aspects such as fatigue (measured with
the FSS scale), the distance covered in the 6MWT and the spirometric test of FVC (Table 4).
In the case of the FSS, different results can be observed depending on the treatment.
There are cases in which patients who performed resistance and strength training at 80% of
their MR worsened, thus increasing their score on the FFS after 1 month of rehabilitation,
obtaining even worse scores than those of the controls of the same study, which were
maintained [11]. However, when reviewing the scores obtained after 1 month of treatment,
another study was favorable and reduced their FFS score [16]. This could be related to
the fact that, in this last study, the rehabilitation consisted in aerobic exercise and did not
include strength exercises, in addition to the fact that it was performed only in three sessions
per week, while in the trial that obtained the worst results, the frequency of training was
daily, i.e., seven sessions per week. This shows the importance of cardiovascular training
in these patients, since the respiratory muscles in more advanced stages of the disease are
severely affected [30]. Cardiovascular training would be the object of study if moderate
aerobic exercise would act as an adjunct against this critical factor of ALS, in order to reduce
the anguish and fatigue that this generates in patients. Although, as has been seen in the
case of multiple sclerosis, the mechanisms related to fatigue and corticospinal function are
altered by the abnormalities in the CNS causing these neurological diseases, the response
to exercise and fatigue seems to be different from that in healthy subjects [31].
However, in both of the aforementioned studies, the distance in the 6MWT was greater
after 1 month [11,16]. Regardless of the fatigue that it caused, it seems that the patients
who underwent strength training and perceived greater fatigue were able to walk a greater
distance compared to that obtained at the beginning of the treatment. Specifically, the
difference was 71 m, and no difference was observed in the controls with usual treatment.
Thus, it seems that, with passive patient care, fatigue can be controlled more safely than
with strength exercises, which can lead to a feeling of exhaustion [32]. However, they seem
to be more capable of performing activities of daily living and their muscles could be more
prepared to carry out fundamental activities (such as walking) for a longer period of time
than patients with a more sedentary lifestyle, according to the results of the compared tests.
This raises questions about the relevance of a balance between perceived fatigue and
the improvements obtained with physical exercise therapy, since what is observed in this
review is that the appearance of fatigue is not always an indication of regression in the
disease, but a stage that sometimes extends to a few days, and rest would be recommended
in them, with continued improvement [11]. For this reason, recovery from this post-training
weakness is of vital importance. In fact, there are studies that focus precisely on the recovery
cycles of muscle speed in relation to the number of motor units and the changes that occur
in sickness [33].
In the longer term, specifically 6 months after beginning of rehabilitation, the FSS
was performed on patients and a score increase on this scale (which was not positive)
was observed in the group that performed the tests. The group that performed exercises
with the highest frequency (5 days/week) showed worse results compared to the group
that had workout sessions 2 days/week [10], which is in line with the results analyzed
after only 1 month of treatment. Consequently, establishing more than 3 days of weekly
training could increase the exhaustion of the patients, according to the scores obtained
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from the FSS. If this fact is related to the measurement of FVC that this trial recorded from
its patients (also at 6 months), it can be seen that the group that worked with a lower
volume of sessions exceeded by more than 10% the group of cases in spirometry. Therefore,
it is suggested that perhaps submaximal aerobic activity in patients with neuromuscular
diseases, allowing for adequate rest, prevents overexertion [34], and that this is not effective
for the achievement of greater lung capacity, although all treatments or physical exercise
programmes must be adapted to the capacities of the patient with ALS [35].
Regarding the rest of the FVC percentages extracted from the long-term studies
reviewed (6 months), it was observed that the patients in the control group had a decrease
of around 15–25% in their spirometric values, while patients in the case groups had a
decrease of around 7–15% in their spirometric values [5,13,15,17]. Therefore, it could be
said that physical exercise therapy has a positive impact on slowing down the deterioration
of the patient’s respiratory muscles.
4.4. Strengths and Weaknesses
As a strength, this is the first scientific document to study the relationship between
therapeutic physical exercise in patients with ALS and the effect it produces in these
subjects, both at a functional level on subjective scales (ALSFRS-R and FSS) and on objective
physiological aspects (FVC and 6MWT).
In this study, the lack of revision of those articles that were not written in one of the
following languages can be considered as a weak point: English, French, German, Spanish
or Portuguese. Likewise, it is possible that certain nuances of the original version of the
analyzed articles may not have been accurately interpreted in their translation.
In addition, those documents that were not included in the analyzed databases
(PubMed, SCOPUS, Cochrane, SciELO, PEDro, CINAHL and MEDLINE) remained outside
the scope of this study.
5. Conclusions
Therapeutic physical exercise could help to slow down the deterioration of the muscu-
lature of people with ALS, thus facilitating their performance of activities of daily living
and, therefore, maintaining the levels of their scores on the ALSFRS-R functionality scale,
especially in the medium and long terms, compared to those in ALS patients with mostly
passive treatments.
The survival of patients did not improve in relation to a therapeutic physical exercise
programme, although their respiratory muscles did improve the levels measured in the
FVC, which leads to an improvement in their quality of life until the end of their disease.
Carrying out a treatment that includes physical activity in patients with ALS helps to
counteract the muscle weakness caused by the degeneration of poorly innervated cells, as
it strengthens healthy cells, and these patients obtained better results in the 6MWT after
several months of rehabilitation.
Regarding the type of exercise, it could be inferred that moderate intensity and not
very high frequencies (two sessions/week), combining strength and aerobic resistance,
could be the best option to observe improvements in patients with ALS and prevent the
onset of fatigue in these patients, since their FSS values may increase with more intense
therapies.
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